These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23210449)

  • 1. Bubble liposomes and ultrasound enhance the antitumor effects of AG73 liposomes encapsulating antitumor agents.
    Hamano N; Negishi Y; Omata D; Takahashi Y; Manandhar M; Suzuki R; Maruyama K; Nomizu M; Aramaki Y
    Mol Pharm; 2013 Feb; 10(2):774-9. PubMed ID: 23210449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced gene delivery using Bubble liposomes and ultrasound for folate-PEG liposomes.
    Omata D; Negishi Y; Hagiwara S; Yamamura S; Endo-Takahashi Y; Suzuki R; Maruyama K; Aramaki Y
    J Drug Target; 2012 May; 20(4):355-63. PubMed ID: 22332850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Ca²⁺ and ATP in enhanced gene delivery by bubble liposomes and ultrasound exposure.
    Omata D; Negishi Y; Yamamura S; Hagiwara S; Endo-Takahashi Y; Suzuki R; Maruyama K; Nomizu M; Aramaki Y
    Mol Pharm; 2012 Apr; 9(4):1017-23. PubMed ID: 22384937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bubble liposomes and ultrasound promoted endosomal escape of TAT-PEG liposomes as gene delivery carriers.
    Omata D; Negishi Y; Hagiwara S; Yamamura S; Endo-Takahashi Y; Suzuki R; Maruyama K; Nomizu M; Aramaki Y
    Mol Pharm; 2011 Dec; 8(6):2416-23. PubMed ID: 22023188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AG73-modified Bubble liposomes for targeted ultrasound imaging of tumor neovasculature.
    Negishi Y; Hamano N; Tsunoda Y; Oda Y; Choijamts B; Endo-Takahashi Y; Omata D; Suzuki R; Maruyama K; Nomizu M; Emoto M; Aramaki Y
    Biomaterials; 2013 Jan; 34(2):501-7. PubMed ID: 23088840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of doxorubicin-encapsulating AG73 peptide-modified liposomes on tumor selectivity and cytotoxicity.
    Negishi Y; Hamano N; Omata D; Fujisawa A; Manandhar M; Nomizu M; Aramaki Y
    Results Pharma Sci; 2011 May; 1(1):68-75. PubMed ID: 25755984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced laminin-derived peptide AG73-mediated liposomal gene transfer by bubble liposomes and ultrasound.
    Negishi Y; Omata D; Iijima H; Takabayashi Y; Suzuki K; Endo Y; Suzuki R; Maruyama K; Nomizu M; Aramaki Y
    Mol Pharm; 2010 Feb; 7(1):217-26. PubMed ID: 20020739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-mediated gene delivery systems by AG73-modified Bubble liposomes.
    Negishi Y; Tsunoda Y; Hamano N; Omata D; Endo-Takahashi Y; Suzuki R; Maruyama K; Nomizu M; Aramaki Y
    Biopolymers; 2013 Jul; 100(4):402-7. PubMed ID: 23532952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
    Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
    Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pDNA-loaded Bubble liposomes as potential ultrasound imaging and gene delivery agents.
    Endo-Takahashi Y; Negishi Y; Nakamura A; Suzuki D; Ukai S; Sugimoto K; Moriyasu F; Takagi N; Suzuki R; Maruyama K; Aramaki Y
    Biomaterials; 2013 Apr; 34(11):2807-13. PubMed ID: 23343634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic delivery systems of angiogenic gene by novel bubble liposomes containing cationic lipid and ultrasound exposure.
    Negishi Y; Endo-Takahashi Y; Matsuki Y; Kato Y; Takagi N; Suzuki R; Maruyama K; Aramaki Y
    Mol Pharm; 2012 Jun; 9(6):1834-40. PubMed ID: 22571418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
    Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A
    Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
    Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
    J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium-based cancer therapeutic liposomes for chemotherapeutics and diagnostics.
    Na K; Lee SA; Jung SH; Shin BC
    Colloids Surf B Biointerfaces; 2011 May; 84(1):82-7. PubMed ID: 21251801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of bubble liposomes and high-intensity focused ultrasound (HIFU) enhanced antitumor effect by tumor ablation.
    Hamano N; Negishi Y; Takatori K; Endo-Takahashi Y; Suzuki R; Maruyama K; Niidome T; Aramaki Y
    Biol Pharm Bull; 2014; 37(1):174-7. PubMed ID: 24389493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PHSCNK-Modified and doxorubicin-loaded liposomes as a dual targeting system to integrin-overexpressing tumor neovasculature and tumor cells.
    Dai W; Yang T; Wang X; Wang J; Zhang X; Zhang Q
    J Drug Target; 2010 May; 18(4):254-63. PubMed ID: 19824864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.
    Garde SV; Forté AJ; Ge M; Lepekhin EA; Panchal CJ; Rabbani SA; Wu JJ
    Anticancer Drugs; 2007 Nov; 18(10):1189-200. PubMed ID: 17893520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.